Research presented at a recent Food and Drug Administration (FDA) workshop indicates the need for more comprehensive testing of new medications in people with obesity.
On January 9th, the American Academy of Pediatrics published new clinical practice guidelines for evaluating and treating obesity in children and adolescents.
Although obesity imposes an enormous burden on our health care system and the economy, the present landscape of coverage for obesity care is piecemeal.